MarketPulse
A

$ARWR

3 articles found
2 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Complement Inhibitors Market Set for Robust Growth Through 2036 as C5, C3 Therapies Expand

Complement inhibitors market projected for strong growth through 2036, driven by rising disease prevalence and C5/C3-targeted drug approvals across multiple indications.
NVSSNYRHHBYAZNREGN+3clinical trialsmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

IgA Nephropathy Market Set to Nearly Quadruple by 2036 Amid Novel Therapy Wave

IgA Nephropathy market projects 18.6% CAGR through 2036 from $1.5B base, driven by novel immunotherapies and recent FDA approvals reshaping kidney disease treatment.
NVSVRTXRHHBYAZNTAK+4clinical trialsgene therapy
BenzingaBenzinga··Vandana Singh

CRISPR Therapeutics Posts Strong Gene Therapy Gains as Casgevy Adoption Accelerates

CRISPR Therapeutics reports strong Q4 results with Casgevy gene therapy generating $116M revenue and 147 patient initiations, signaling accelerating adoption and market confidence.
LLYVRTXREGNCRSPARWRsickle cell diseaseCasgevy